A MichBio e-publication
November 2014

Member News
MichBio Events
Featured Events
January 12-14

MichBio Premium Members




Michigan State University


University of Michigan


Johnson & Johnson

MPI Research




On the Road 
Stephen Rapundalo, PhD 
President & CEO, MichBio

The year keeps racing past as we near its end...unbelievable where the time has gone.


When we last left off, I was on my way to the MD&M Chicago 2014 Conference and Exhibition. There I chaired an all-day session on various topics related to "Designing Next Generation Medical Devices". Morning speakers presented on miniaturization and new power technology, as well as on protecting IP and new design. Two workshops - "Innovation that Matters: Cost & Patient Safety" and "Human Factors" - were delivered in the afternoon. Session speakers were from a cross-section of the industry - Covidien, CareFusion, Medtronic, MicroSystems Engineering, WiTricity, and others. [Read more]


MichBio Offers 3x Return at 2015 JPMorgan Healthcare Conference!

Ease into JPM with a Glass of Wine

Join us for the State Bio Friends Wine Reception at ENO Wine Bar in Union Square, where we will kick off your conference week in California wine style! The state bioscience associations of Michigan, New York, Virginia, and Washington have joined to offer a great afternoon of wine and networking.

Sunday, January 11
4:00-7:00 PM

ENO Wine Bar

320 Geary St.

San Francisco, CA 94102


All are invited! 
Can't Attend JPM?
MichBio Will Partner for You.

Let us "take you along" to JPM. Simply sign up with our BioConnections business referral program and we'll seek out partnering opportunities on your behalf. We know that emerging companies don't have the means to attend every business development/ partnering meeting out there, so let us do it for you at no cost. This service is ONLY for MichBio members.


Complete your BioConnections application here. If you already have one on file with us email srapundalo@michbio.org to renew your interest.


Any MichBio bioscience member company is eligible if you have an active product/ technology portfolio with an interest to in- or out-license/partner in the following:

  • Therapeutic or consumer healthcare products
  • Diagnostic products
  • Platform technologies (including IT)
  • Medical devices and technologies

We recommend that companies be in late pre-clinical or early clinical development phases to increase the likelihood for any interest by outside parties. CROs or companies otherwise providing services will not be considered.


Veni, Vidi, Vici the Biotech Showcase 2015
Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the JP Morgan Conference.
MichBio Members receive a $200 discount!  [More details]  

Survey - in partnership with BIO

Seeking participants to provide input for BIO's first-of-its-kind survey tool on FDA/Sponsor Interactions During Drug Development.

A new type of real-time survey initiative, participants will have access to the survey tool 24 hours a day, 7 days a week so that responses can be updated on a continuous basis.


Participants will be asked to provide responses about individual clinical programs for products that are currently at any point from the pre-clinical testing phase through the clinical testing phase, prior to submission of an initial NDA/BLA.


Learn more about the survey's purpose, benefits and privacy information.



Legal Column

Do Not End Up with an Unenforceable Patent - It's Your Hard-Earned Patent 

Vara Prasad, V.N. Josyula, Ph.D.

Honigman Miller Schwartz and Cohn LLP

In general, many people are aware of the value of patenting an idea or invention, filing a patent application, and getting it granted. Moreover, most applicants are aware of the costs associated with the patent prosecution process and payment of maintenance fees throughout the patent's life cycle. However, many people, even many inventors, are not aware that a patent can be unenforceable due to violation of duty of disclosure and/or inequitable conduct. It is possible (vide infra) that one could end up with an unenforceable patent by not following the simple rules and laws related to the intellectual property. [Read More]

Help Shape MichBio U in 2015: Call for Topics and Speakers


We launched MichBio U this past year to provide additional knowledge and education for our companies in an easy, webinar-based format. Response to our programming was very positive and we hope to build on that foundation going forward.


So help us shape the MichBio curriculum in 2015. Be a speaker and/or suggest a topic! [Read more]


Please forward any proposals or questions regarding this new program to David McGuire, Director of Membership & Operations, at david@michbio.org.




Device Tax Survey from MDMA

MDMA is conducting a short and anonymous survey to gauge how the industry is addressing the 2.3% medical device tax, and how repeal of this policy would allow companies to invest in innovation. 
Responses are due Friday, December 5, 2014. This brief survey consists of 10 short questions. 

Funding Announcement
Pediatric Device Commercialization Gap Funding

The Michigan Pediatric Device Consortium (M-PED) is pleased to announce its Request for Applications for gap funding for pediatric medical devices, including apps. M-PED is seeking proposals from inventors in medical institutions, private practices, the business community, and academic research who have medical device concepts for use with pediatric patients. Proposals should address an unmet need within the pediatric population with a device idea that lends itself to commercialization. Awards of $20-50,000 may be granted to each of 3-6 projects. Projects that are past the prototype stage are encouraged to apply.


The application process has two stages. A 2-page written pre-proposal is due on December 8th, 2014.  Selected applicants will be invited by December 23rd to submit a full 6-8 page proposal due on Friday, January 9th, 2015. Awards will be announced after January 20th, 2015.


[More Details]


Funding Opportunities 
Stay Connected